Technology
HEALTHTECH INNOVATION DAYS , 4th EDITION
UNDER HIGH PATRONAGE FRENCH PRESIDENT
Alison MUNRO Host Event (Source: © Ruby BIRD & Yasmina BEDDOU)
USPA NEWS -
The HealthTech Innovation Days Event, initiated by France Biotech, provides a Platform for promising European Life Sciences Companies to accelerate their growth and bring Innovation to Patients. The 4th Edition, organized by HealthTech For Care, took place on October 13 & 14, 2022 on a Hybrid Format @ Palais Brongniart in Paris.
The HealthTech Innovation Days Event, initiated by France Biotech, provides a Platform for promising European Life Sciences Companies to accelerate their growth and bring Innovation to Patients. The 4th Edition, organized by HealthTech For Care, took place on October 13 & 14, 2022 on a Hybrid Format @ Palais Brongniart in Paris.
The HTID (HealthTech Innovation Days) is sponsored by International Pharmaceutical Companies, other Corporates, Investors, and many International though Leaders & KOLs.
The HTID (HealthTech Innovation Days) is sponsored by International Pharmaceutical Companies, other Corporates, Investors, and many International though Leaders & KOLs.
Participation:
- +800 in Paris & Virtually
- +165 European Healthcare Companies selected
- +15 Pharmaceutical Companies
- 25 selected Companies to pitch
- 26 Sponsors
- +1,600 Networking & Private Meeting
- +18 Countries represented
- +300 International Investors
- 86 Speakers
- +19 Sessions over 2 Days
- +800 in Paris & Virtually
- +165 European Healthcare Companies selected
- +15 Pharmaceutical Companies
- 25 selected Companies to pitch
- 26 Sponsors
- +1,600 Networking & Private Meeting
- +18 Countries represented
- +300 International Investors
- 86 Speakers
- +19 Sessions over 2 Days
Source: © Ruby BIRD & Yasmina BEDDOU
Source: © Ruby BIRD & Yasmina BEDDOU
PROGRAMME
Thursday, October 13th
- Build tomorrow’s healthcare for all European citizen
- Funding Innovation: is there a creative approach smarter than pouring money?
- Age-related diseases, a continuum from birth to death
- How collaboration between pharmaceutical and biotech companies may unleash the full potential of cell therapy?
- A vision of the future: European health systems transformations in 2032
- Covid wake up call on health innovation investments – Opportunities and turbulence
- Particularities of investing in digital health
- How AI is revolutionizing the patient-doctor relationship
- Translational microbiome medicine to treat serious oncology and infectious diseases
- People at the heart of Life Science Investing: in conversation with Sabine Dandiguian, Managing Partner, Jeito Capital
Thursday, October 13th
- Build tomorrow’s healthcare for all European citizen
- Funding Innovation: is there a creative approach smarter than pouring money?
- Age-related diseases, a continuum from birth to death
- How collaboration between pharmaceutical and biotech companies may unleash the full potential of cell therapy?
- A vision of the future: European health systems transformations in 2032
- Covid wake up call on health innovation investments – Opportunities and turbulence
- Particularities of investing in digital health
- How AI is revolutionizing the patient-doctor relationship
- Translational microbiome medicine to treat serious oncology and infectious diseases
- People at the heart of Life Science Investing: in conversation with Sabine Dandiguian, Managing Partner, Jeito Capital
Source: © Ruby BIRD & Yasmina BEDDOU
Source: © Ruby BIRD & Yasmina BEDDOU
Friday, October 14th
- In vitro diagnostics industry in Europe: at the heart of patient’s care
- Being Listed: Challenges and Opportunities
-Matching the required talents for a sustainable development: constraints and opportunities!
- Impact of mRNA application in innovative drugs with the support of adapted manufacturing settings (In the memory of François Gros)
- Closing the gap in Women’s Health: we need to be the change
- Digital innovation tools empowering patients in collaboration with health-tech, pharma and investors
- Social impact of an effective North Atlantic Bridge for long-term innovation
- In vitro diagnostics industry in Europe: at the heart of patient’s care
- Being Listed: Challenges and Opportunities
-Matching the required talents for a sustainable development: constraints and opportunities!
- Impact of mRNA application in innovative drugs with the support of adapted manufacturing settings (In the memory of François Gros)
- Closing the gap in Women’s Health: we need to be the change
- Digital innovation tools empowering patients in collaboration with health-tech, pharma and investors
- Social impact of an effective North Atlantic Bridge for long-term innovation
Source: © Ruby BIRD & Yasmina BEDDOU
Source: © Ruby BIRD & Yasmina BEDDOU
Pitch sessions & Award
HealthTech For Care is launching for the first time a pitch competition for European healthcare companies committed to patients. The purpose is to offer these companies the opportunity to present their solutions to healthcare professionals and investors. The winner will receive the “HealthTech For Care innovation” award, which goes along with privileged connections with HTFC sponsors, visibility through dedicated communication and free access to the 5th edition of the HealthTech Innovation Days (HTID®) event.
HealthTech For Care is launching for the first time a pitch competition for European healthcare companies committed to patients. The purpose is to offer these companies the opportunity to present their solutions to healthcare professionals and investors. The winner will receive the “HealthTech For Care innovation” award, which goes along with privileged connections with HTFC sponsors, visibility through dedicated communication and free access to the 5th edition of the HealthTech Innovation Days (HTID®) event.
Source: HealthTech Innovation Days - 4th Edition
@ Palais Brongniart in Paris
October 13th & 14th, 2022
Under the High Patronage of Mr. Emmanuel Macron, President of the French Republic
We are moving into a period of unprecedented change – the 4th Industrial Revolution. Artificial intelligence, automation, and big data have all moved beyond their infancy, forcing leaders to grapple with a set of newly evolved challenges in healthcare.
Ruby BIRD
http://www.portfolio.uspa24.com/
Yasmina BEDDOU
http://www.yasmina-beddou.uspa24.com/
@ Palais Brongniart in Paris
October 13th & 14th, 2022
Under the High Patronage of Mr. Emmanuel Macron, President of the French Republic
We are moving into a period of unprecedented change – the 4th Industrial Revolution. Artificial intelligence, automation, and big data have all moved beyond their infancy, forcing leaders to grapple with a set of newly evolved challenges in healthcare.
Ruby BIRD
http://www.portfolio.uspa24.com/
Yasmina BEDDOU
http://www.yasmina-beddou.uspa24.com/
more information: https://https://htfc-eu.com/htid4-agenda/
Ruby Bird Yasmina Beddou European Healthcare Companies Conferences Pitches 4th Edition Corporates Kol Pharmaceutical Companies Investors Palais Brongniart October 13 14 2022 Healthtech For Care Healthtech Innovation Days France Biotech
Liability for this article lies with the author, who also holds the copyright. Editorial content from USPA may be quoted on other websites as long as the quote comprises no more than 5% of the entire text, is marked as such and the source is named (via hyperlink).
